RxDoctor Payments Data

Philip Boucher

Pediatrics · Omaha, NENPI 1962796839

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $10,290 of the $10,306 with a category attached, or 99.8%. AstraZeneca accounts for 99.8% of it on its own, with 1 other manufacturer making up the rest. Among pediatrics clinicians in NE with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$10,306in general payments, 2019–2025

Across 2 payments — averaging $5153.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$10K
  • Sanofi$16
$939,623in research payments, 2019–2025

Across 126 payments — averaging $7457.33 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • GSK$557K
  • Novavax Inc$181K
  • Modernatx, Inc.$143K
  • Sanofi Pasteur Inc.$59K

What the payments were for

  • Consulting fees$10,290100%
  • Food & beverage$160%

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca1$10,290
Sanofi1$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,306 in reported general payments places this provider in the 95th percentile of 308 pediatrics providers in Nebraska.

See all pediatrics providers in Nebraska

Other pediatrics in Omaha

See the full list for Nebraska

Where these figures come from

Is this you, or does something look wrong? →